SFI
VCYT icon

Susquehanna Fundamental Investments’s Veracyte VCYT Stock Holding History

Susquehanna Fundamental Investments’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,190
Closed -$607K – 1909
2021
Q2 		$607K Buy
+15,190
New +$650K 0.01% 1075

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Susquehanna Fundamental Investments's VCYT Position: Q3 2021 in Review

Susquehanna Fundamental Investments sold out of Veracyte (VCYT) in Q3 2021, closing a stake of 15,190 shares — an estimated $607K sold.

Susquehanna Fundamental Investments first reported a position in VCYT in Q2 2021 and held it in 1 quarter. The position peaked at $607K in Q2 2021. 214 funds tracked by Wall St. Rank hold VCYT as of Q3 2021.

  • Susquehanna Fundamental Investments reported no remaining Veracyte position as of Q3 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 15,190 Veracyte shares in Q3 2021, an estimated $607K.
  • Susquehanna Fundamental Investments first reported a position in Veracyte in Q2 2021 and held it in 1 quarter.
  • Susquehanna Fundamental Investments's Veracyte position peaked at $607K in Q2 2021.
  • 214 funds tracked by Wall St. Rank held Veracyte as of Q3 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2021, filed 15 Nov 2021.